LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

The sp is already up with events, it would take an incredible optimistic rns to send this past 20p...but I suppose if the whole world buys the shares it will rise even if there is just 5000 worth of earnings....it takes some doing to put a valuation of 80 million on a company....the sp is up with events and well ahead...there has to be a massive contract and sale of products coming to justify this price tag....and beware of another EK short coming....

There's also this, taken from an article at around that time (19 November 2007) re Unilever's involvement:

"The original Fruitflow is a thick, sugary syrup - ideal for juice drinks like Sirco but with a strong flavour and colour that makes it unsuitable for dairy and other foods. An existing agreement with branding giant Unilever is intended to solve this, and Provexis indicated in its interim results that this partnership will be extended by another 12 months."

Hope this helps

The CEO has said they have contracts in the pipeline ready to go once the official EU approval is rec. on the wording to be used. These multi national cos will hold back until then but we already know that one has a major stake in the co.--others are probably lining up for a piece of the action assuming the extract can be used in a variety of products for differing medical conditions. The CEO also said penicillin was produced by a small team of 6 scientists--when quizzed about his tiny co.
sirco--also good for addled brains to increase the blood flow!! lol.

Toya---snap!

Worth 80 million.....pleeezzze....it's nonsense....even if there is a big contract coming they will only take a percentage...it's like a farmout for an oil company....are we all going to be taking fruity fruitflow instead of nurofens now ?....perhaps not !.

This is a company that should be worth 10 to 20 million at the most....I mean that is a staggering amount of money as it is !.....80 million and no revenue ?...you lot live in dream world...even if they start producing tomorrow under licence these miracle pills which they won't, the revenue will be of a small percentage like 20% of whatever they sell.....we are a long way off from that....

MP: yes, snap! There's loads we could say here, but best not overload addled brains, especially on top of a bottle of wine (well, half a bottle).

RF: I think on this one you'll kick yourself before the year is out.

No, because I will buy in if you lot convince me otherwise...it's just that we have the benefit of deja-vu ...with SEO.....this is risky.....it could be worthless in fact...tomato extract turned into aspirin...and everybody going to drop their pills for this new wonder....they would have to price it at a 50% discount to the painkillers that are around at the moment....!.

RF put the life jacket back on, you jumped ship tooooo soon. lol

as we wait for our rewards on pxs--check out chwi, ygh if you think china has a booming future. Those are my latest hot picks to tuck away--plus mta. dyor of course.

The potential for this product is M A S S I V E! And thats not an under statement. If anybody does their research here.they we see that. Even cynic is beginning to believe lol. gl

Lol indeed! - but then he is called 'cynic'

RF, seems you have made your mind up which is fine, others have followed up my post with somne details and noted that there is no point in posting the whole research that makes us believe in this company.

The fact that you think we are talking about aspirin use for headaches says it all.

I agree with your caution (which is valid) but unfortunately it is not based on the full picture. You talk about being into oil and we see all the valuations based on (gu)estimates of the amount of barrels of oil in the ground and then you say that you are suspect of the valuation of this product. We are looking at potential rather than actual income currently and their is, as always, a risk of the whole thing underperforming - I have been in this for 4 years or so and spent long enough at a loss and in the doldrums at 1p whilst all the potential was building up and it has now broken free.

You need to make your own decisions/judgements and thats important. Keep us on the ground, if you can.

first of all, many thanks to you all for enlightening me a little, though i still do not understand why this long drawn-out nonsense about wording - wording of what exactly???

anyway, i have an even more jaundiced view of snakeoil manufacturers than onfmost others, and with good reason - few of them last the course and even SHP, which i have followed for a long time and is very successful, has had a pretty volatile ride.

had i known about PXS 2 years ago, i might well have been suckered by the seemingly imminent golden future and been walloped accordingly.

today, things are apparently greatly different, but the question to be asked apart from the obvious, is whether or not the company is truly worth its 100m valuation today, and that is not at all obvious.

the only thing that keeps me in, way beyond my initial and then subsequent target, is that sp continues to rise (again this morning) with very high volumes, but common sense - which may or may not prevail - dictates that at least partial profits should now be taken or even have been taken.

It's up again !....probably just on volume and potential....I just can't see what the market seems to be seeing.

This product is scientifically proven, and now efsa have approved this. We are now only waiting on the EC to approve wording for the product in laymans wording. For example Danones yogurt says improves digestive tract. If they put on the side of what ever packet, the full scientific wording, joe public wouldnt understand it. Once this is approved then i feel that deals are already in place and this will fly. imvho

2.3 million traded in the first twenty minutes

SEO has a proven product too; it's just that no one will buy it and/or SEO can't actually produce it commercially!

market cap 100 million and rising...incredible...

From Foodeagle on iii


I am still waiting for the final EU wide approval of the claim by the EU Commission ("wording") on fruitflow (@ guys, EFSA has done its job, it is now up to the EU Commission to do its legal act: the approval of a consumer understandable wording). This would reasonable open the entire EU market for PXS (and its future partners), a huge market from which 90 % of the functional food industry will have to leave in 2010 because their claims have not been scientifically confirmed by EFSA.

I must admit, it is much nicer to wait for the next steps ("Wording", & "transformational steps") when PXS SP is double digits and rising than at 5-6 p and falling.

Some traders left 15+ (congrats, at least so far), many others left with losses in panic at less than 10p. That's what I have meant, that the market (and its volatility) will kick out most of those who did not a proper research on PXS, and on the regulatory framework. I am sure that this extreme volatility and the sharp drop once intraday towards 4 pc after the high, resulted that now the shares are in stronger hands than they had been before> good for the SP. The opportunities are extremely significant IF the fruitflow versus Asprin trial reveals results showing that fruitflow is as effective as Aspirin (but with less or no side effects).

However, my short-medium expectations (until end of this years) have been alsways been based on the "wording", the following deals with majors and the media coverage will be very supportive for the PXS SP towards the end of this year, less on the trial. It is almost impossible to predict any price, but if the next steps come as I expected, I would say PXS should easily make new all time highs, maybe 25-30 p by end this year.

I am not a good trader, and my holdings are too large for this stock to trade, so I "do not have" another choice than just to wait and see, if my assumptions were right and re-evaluate when something significant happens. So basically, nothing new what I could tell you.

From the SP and the volumen, it seems to me that something happened on Friday late morning, which seems to responsible for the recent ride (?) at least that's my feeling.